INTRODUCTION: Subject recruitment is critical for understanding fatal diseases like ALS, however linking patients with researchers can be challenging. The U.S. population-based National ALS Registry allows recruitment of persons with ALS (PALS) for research opportunities. METHODS: The Registry's Research Notification Mechanism was used to recruit PALS aged ≥21 years; participants completed a Web-based epidemiologic survey. PALS (n = 2,232) were sent an email describing the study, and 268 surveys were completed. RESULTS: The mean age (± SD) of eligible participants was 57.7 ± 9.3 years for men and 61.5 ± 8.9 for women. Most were men (63%) and Caucasian (92%). Of 256 potentially eligible participants, 37.5% (n = 96) returned an authorization to disclose protected health information. ALS was confirmed for 94% (83/88) from physician responses. CONCLUSIONS: This analysis demonstrates the National ALS Registry's usefulness in recruiting PALS for research. This recruitment source can potentially foster the discovery of better treatment options and therapies, and of prevention strategies.
INTRODUCTION: Subject recruitment is critical for understanding fatal diseases like ALS, however linking patients with researchers can be challenging. The U.S. population-based National ALS Registry allows recruitment of persons with ALS (PALS) for research opportunities. METHODS: The Registry's Research Notification Mechanism was used to recruit PALS aged ≥21 years; participants completed a Web-based epidemiologic survey. PALS (n = 2,232) were sent an email describing the study, and 268 surveys were completed. RESULTS: The mean age (± SD) of eligible participants was 57.7 ± 9.3 years for men and 61.5 ± 8.9 for women. Most were men (63%) and Caucasian (92%). Of 256 potentially eligible participants, 37.5% (n = 96) returned an authorization to disclose protected health information. ALS was confirmed for 94% (83/88) from physician responses. CONCLUSIONS: This analysis demonstrates the National ALS Registry's usefulness in recruiting PALS for research. This recruitment source can potentially foster the discovery of better treatment options and therapies, and of prevention strategies.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz Journal: Lancet Date: 2014-02-28 Impact factor: 79.321
Authors: Yanli Zhao; Merit E Cudkowicz; Jeremy M Shefner; Lisa Krivickas; William S David; Francine Vriesendorp; Alan Pestronk; James B Caress; Jonathan Katz; Ericka Simpson; Jeffrey Rosenfeld; Robert Pascuzzi; Jonathan Glass; Kourosh Rezania; Jerold S Harmatz; David Schoenfeld; David J Greenblatt Journal: J Clin Pharmacol Date: 2014-05-16 Impact factor: 3.126
Authors: Merit E Cudkowicz; Leonard H van den Berg; Jeremy M Shefner; Hiroshi Mitsumoto; Jesus S Mora; Albert Ludolph; Orla Hardiman; Michael E Bozik; Evan W Ingersoll; Donald Archibald; Adam L Meyers; Yingwen Dong; Wildon R Farwell; Douglas A Kerr Journal: Lancet Neurol Date: 2013-09-23 Impact factor: 44.182
Authors: Angela M Malek; Aaron Barchowsky; Robert Bowser; Terry Heiman-Patterson; David Lacomis; Sandeep Rana; Ada Youk; David Stickler; Daniel T Lackland; Evelyn O Talbott Journal: Neurodegener Dis Date: 2013-11-12 Impact factor: 2.977
Authors: Nikolas Dietzel; Lara Kürten; Linda Karrer; Michael Reichold; Laura Köhler; Andreas Nagel; Christina Chmelirsch; Kathrin Seebahn; Markus Hladik; Sebastian Meuer; Anna Kirchner; Kristina Holm; Marina Selau; Marco Wendel; Jörg Trinkwalter; Hans-Ulrich Prokosch; Elmar Graessel; Peter L Kolominsky-Rabas Journal: BMJ Open Date: 2021-02-08 Impact factor: 2.692
Authors: Karin N Wagner; Haikady N Nagaraja; Dawn C Allain; Adam Quick; Stephen J Kolb; Jennifer Roggenbuck Journal: Mol Genet Genomic Med Date: 2017-12-20 Impact factor: 2.183
Authors: Paul Mehta; Jaime Raymond; Moon Kwon Han; Theodore Larson; James D Berry; Sabrina Paganoni; Hiroshi Mitsumoto; Richard Stanley Bedlack; D Kevin Horton Journal: J Med Internet Res Date: 2021-12-07 Impact factor: 5.428